|
|
Maps to AVAC Observing SitesDriving Directions To:
Saddleback Butte State ParkLOCATION: Lat 34.67 N, Long 117.82611 W. ALTITUDE: 2800 ft Saddleback Butte Seeing Conditions Saddleback Butte Automated Weather Center Poppy ReserveLOCATION: ALTITUDE: 3057 ft Antelope Valley Poppy Reserve Mojave Desert State Parks-Ave. I and 165th St. West, Lancaster (661) 942-0662. Take Ave. I west to approximately 165th St. West to the Reserve entrance.
Mt. WilsonLOCATION: Lat 34 13" 27.4' N, Long 118 03" 50.3' W. ALTITUDE: 5680 Feet Weather: http://weather.yahoo.com/forecast/USCA0742.html
Red Rock Canyon State ParkLOCATION: Lat 35.22.38 N Long -117.59.38 W. ALTITUDE: 2567 ft
Mt. PinosLOCATION: Lat 34.8332134 N Long -119.167 W. ALTITUDE: 8300 ft
Detailed information about Mt. Pinos can be found here. You will take one and half hours from Palmdale to Mt. Pinos. Take Hwy 14 North to the Hwy 138 off-ramp. Go over Hwy 138 and continue west on Hwy 138 to the I-5 North on-ramp. Continue on I-5 North just past Gorman and take the turn-off on the Frazier Park off-ramp. Turn left underneath I-5 and continue west for 21 miles to Mt. Pinos. (You will pass Frazer Park and follow signs to Mt. Pinos Recreation Area.) After passing through two seasonal snow gates, keep going another 3 1/2 miles. The observing site is a large paved parking area at the very end of the road, at 8300 ft elevation. There is no water there. You must bring you own. We are roughing it. There are portable restrooms. The skies can be fantastic. The temperature can be very cold - even in the Summer! You may camp overnight in the walk in campground only. Check out the information below for the latest sky conditions at Mt. Pinos. MAP TO MT. PINOS
For weather call Frazier Park Forest Service 805-245-3731. For real time weather on the internet visit http://www.frazmtn.com/pmcwebcam
Riverside Telescope Makers Conference And Telescope Expo(RTMC) Location:
Questions? If you have any questions about the Riverside Telescope Makers Conference or would like to request additional registration materials, please call (909) 948-2205, or send e-mail to Robert Stephens at registrar@rtmc-inc.org. Our postal address is: Riverside Telescope Makers Conference and Telescope Expo, Inc. 8300 Utica Avenue, Suite 105 Rancho Cucamonga, CA 91730 (909) 948-2205
Augmentin is used to treat many different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.
Augmentin 635mg $118.13 - $1.97 Per pill
Augmentin price dischem es to include other classes of cancer, and has the potential to substantially lower prices of these therapeutic classes. Our pharmaceutical development strategy requires the acquisition of novel compounds that are designed to treat a specific area of the disease. We have established a strategy to develop novel agents treat a number of targeted cancers in an opportunistic manner. The initial focus has been on patients with cancer that are resistant or sensitive to conventional medications. We believe our approach is the most promising to rapidly develop effective new cancer therapeutics using the technology that we developed for the discovery of human TGFβ superfamily. We have taken steps through our pharmaceutical development program at partner to achieve the following: (i) Acquiring and developing molecules targeting a specific molecular target; and (ii) Accelerating the development of these molecules for use in drug therapy by addressing, an opportunistic way, the unique and requirements of each disease. In the last three years, our pipeline focused on the cancer areas of TGFβ receptor mutations and breast cancer. We have also pursued a few novel therapies that target, in an opportunistic manner, specific TGFβ receptor molecular targets and for which we have acquired a product strategy and scientific lead, where we have completed Phase I clinical trials. We expect that this process, driven by our pharmaceutical development strategy, will be able to increase our pipeline offerings and address need for products to effectively address our Purchase valtrex cancer targets. We believe this acceleration of the development new therapeutic candidates to address our ongoing clinical trial programs will increase our commercial exposure to the TGFβ signaling pathway and ultimately our ability to commercialize these therapies. We intend to continue focus on: Our development pipeline of TGF receptor molecules for the treatment of cancer. Our ability to accelerate the development of our own drug products for current clinical trial and therapeutic products for other clinical programs. We expect to continue develop and advance these therapeutic products by: Increasing our capacity to recruit new collaborators, especially in the areas of cancer and oncology; Increasing our ability to engage in the strategic partnership approach, which is the best way to develop a new drug. Collaboration with industry is a unique approach to drug development; and Accelerating our strategic relationship with Merck & Co. and Pfizer, with whom we have a strategic partnership agreement. In addition, we expect our research and development activities to result in the development of TGFβ receptor inhibitors and antagonists. The clinical development efforts associated with each of our drug programs will be the primary determinant of our ability to commercialize any of our compounds in the future. If we succeed in achieving all of our planned research and development goals, our product pipeline successfully addresses current drug programs, we believe will be able to capitalize on |